Identification of terfenadine as an inhibitor of human CD81-receptor HCV-E2 interaction: synthesis and structure optimization
…, B Albrecht, B Kronenberger, A Kaul, R Bartenschlager…
Index: Holzer, Marcel; Ziegler, Sigrid; Albrecht, Beatrice; Kronenberger, Bernd; Kaul, Artur; Bartenschlager, Ralf; Kattner, Lars; Klein, Christian D.; Hartmann, Rolf W. Molecules, 2008 , vol. 13, # 5 p. 1081 - 1110
Full Text: HTML
Citation Number: 16
Abstract
Abstract: Terfenadine (4-[4-(hydroxydiphenylmethyl)-1-piperidyl]-1-(4-tert-butyl-phenyl)- butan-1-ol) was identified in a biological screening to be a moderate inhibitor (27% inhibition) of the CD81-LEL–HCV-E2 interaction. To increase the observed biological activity, 63 terfenadine derivates were synthesized via microwave assisted nucleophilic substitution. The prepared compounds were tested for their inhibitory potency by means of ...
Related Articles:
[El Ouarradi, Amane; Salard-Arnaud, Isabelle; Buisson, Didier Tetrahedron, 2008 , vol. 64, # 51 p. 11738 - 11744]
[Zhang; Ter Laak; Timmerman European Journal of Medicinal Chemistry, 1993 , vol. 28, # 2 p. 165 - 173]
[Yang; Prakash; Roden; Snyders British Journal of Pharmacology, 1995 , vol. 115, # 2 p. 267 - 274]
[Lafite, Pierre; Dijols, Sylvie; Buisson, Didier; Macherey, Anne-Christine; Zeldin, Darryl C.; Dansette, Patrick M.; Mansuy, Daniel Bioorganic and Medicinal Chemistry Letters, 2006 , vol. 16, # 10 p. 2777 - 2780]